Axsome Therapeutics, Inc. <AXSM.O>: Truist Securities Assumes Coverage With Buy Rating; Target Price $285 vs $200
AXSM•Related News
Rivian Is Recalling 98,828 U.S. Vehicles As An Obstructed Rearview Camera Image Can Reduce Driver's View Behind Vehicle - NHTSA
RIVN•
Fresenius Medical Care probes cybersecurity incident after unauthorized access to internal systems
FMS•
Rupee edges lower as dollar firms on Fed hike wagers
TLT•
Europe stocks rise as oil retreat aids sentiment; PMI data in focus
FEZ•
Micron Technology, Inc. <MU.O>: Citigroup Raises Target Price to $1300 From $1150
MU•